new york times fda questions lilly document february company found patients taking zyprexa clinical trials three half times likely develop high blood sugar take drug document submitted agency months later lilly provided data fda showed almost difference blood sugar patients took zyprexa worry lilly claiming honest mistake kind large mistake eh data analyzed accurately zyprexa appear nearly risky course sure lilly honest like said never marketed zyprexa treatment dementia time said zyprexa cause diabetes maybe lilly decided sell zyprexa safe gentle psychotropic i think get point indeed possible lilly truthful i personally doubt side note good see alex berenson back writing zyprexa